Company: CERO
Filing Date: 2025-11-17
Form Type: PRE 14A
Source: 0001213900-25-111175
Chunk: 94

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-17
Form: PRE 14A
Chunk 94
---
 and GVN, LLC (of which Mr. Atwood and Lynne H. Edminster serve as managers, and the sole member is the Trust) that are in excess of the applicable beneficial ownership limitations. (6)Consists of 2,388shares of Common Stock issuable pursuant to stock options exercisable within 60 days of November 12, 2025. (7)Consists of (i) 3shares of Common Stock held by Kathleen LaPorte, (ii) 483shares of Common Stock, held by the Kathleen LaPorte Revocable Trust, of which Ms. LaPorte serves as a trustee, and (iii) 2,388shares of Common Stock issuable pursuant to stock options exercisable within 60 days of November 12, 2025. (8)Consists of 2,388shares of Common Stock issuable pursuant to stock options exercisable within 60 days of November 12, 2025. (9)Consists of 2,353shares of Common Stock issuable pursuant to stock options exercisable within 60 days of November 12, 2025. 53 STOCKHOLDER PROPOSALS Stockholders intending to present a proposal to be considered for inclusion in the proxy statement for the Company’s 2026 Annual Meeting of Stockholders must submit a proposal that is received at the Company’s principal executive offices at a reasonable time before the Company begins to print and send its proxy materials for that meeting. Such stockholder proposals intended to be included in the proxy statement for the next annual meeting of our stockholders in 2026 must also satisfy the requirements of Rule 14a -8under the Exchange Act, and be received no later than January 7, 2026, in order to be considered for inclusion in the proxy materials to be disseminated by the board of directors for such annual meeting. Proposals must be sent via registered, certified, or express mail (or other means that allows the stockholder to determine when the proposal was received by the Secretary) to the Company’s Secretary at CERo Therapeutics Holdings, Inc., 201 Haskins Way, Suite 230, South San Francisco, CA 94080. Proposals must contain the information required under the Company’s Bylaws, a copy of which is available upon request to the Company’s Secretary, and also must comply with the SEC’s regulations regarding the inclusion of stockholder proposals in Company -sponsoredproxy materials. Stockholders intending to present a proposal